United Therapeutics (UTHR) investor relations material

Opening remarks and agenda

• The meeting was held virtually on the company's 30th anniversary, with introductions of key executives and board members present online.

• The agenda and rules of conduct were made available on the virtual meeting website, with instructions for participation and technical contingencies.

Board and executive committee updates

• All 12 director nominees were introduced for election to serve one-year terms until the next annual meeting.

• Key board members and committee chairs were present, including the Lead Independent Director and Nominating and Governance Committee Chair.

Shareholder proposals

• Four proposals were presented for voting: election of directors, advisory approval of executive compensation, approval of the 2026 Stock Incentive Plan, and ratification of the independent auditor.

• The board recommended voting in favor of all nominees and proposals.